Therefore, this study evaluated the treatment potential of miR-214-3p delivered by MSCs-exo in AD through targeting CD151, aiming to provide a novel reference for drug delivery systems and miRNA-targeted therapy for AD. The gene discussed is CD151; the disease is Alzheimer disease.